Anatomical-Guided Attention Enhances Unsupervised PET Image Denoising Performance

TL;DR

This paper introduces an unsupervised PET image denoising method that leverages anatomical-guided attention mechanisms, improving image quality and enabling reduced scan times and tracer doses in PET imaging.

Contribution

The proposed MR-GDD method effectively incorporates anatomical guidance via attention gates, enhancing unsupervised PET denoising performance across various clinical and preclinical datasets.

Findings

Achieved highest PSNR and SSIM in Monte Carlo simulations.

Demonstrated state-of-the-art denoising in clinical and preclinical PET studies.

Reduced PET scan times and tracer doses without loss of image quality.

Abstract

Although supervised convolutional neural networks (CNNs) often outperform conventional alternatives for denoising positron emission tomography (PET) images, they require many low- and high-quality reference PET image pairs. Herein, we propose an unsupervised 3D PET image denoising method based on an anatomical information-guided attention mechanism. The proposed magnetic resonance-guided deep decoder (MR-GDD) utilizes the spatial details and semantic features of MR-guidance image more effectively by introducing encoder-decoder and deep decoder subnetworks. Moreover, the specific shapes and patterns of the guidance image do not affect the denoised PET image, because the guidance image is input to the network through an attention gate. In a Monte Carlo simulation of [$^{18}$F]fluoro-2-deoxy-D-glucose (FDG), the proposed method achieved the highest peak signal-to-noise ratio and structural similarity (27.92 $\pm$ 0.44 dB/0.886 $\pm$ 0.007), as compared with Gaussian filtering (26.68 $\pm$ 0.10 dB/0.807 $\pm$ 0.004), image guided filtering (27.40 $\pm$ 0.11 dB/0.849 $\pm$ 0.003), deep image prior (DIP) (24.22 $\pm$ 0.43 dB/0.737 $\pm$ 0.017), and MR-DIP (27.65 $\pm$ 0.42 dB/0.879 $\pm$ 0.007). Furthermore, we experimentally visualized the behavior of the optimization process, which is often unknown in unsupervised CNN-based restoration problems. For preclinical (using [$^{18}$F]FDG and [$^{11}$C]raclopride) and clinical (using [$^{18}$F]florbetapir) studies, the proposed method demonstrates state-of-the-art denoising performance while retaining spatial resolution and quantitative accuracy, despite using a common network architecture for various noisy PET images with 1/10th of the full counts. These results suggest that the proposed MR-GDD can reduce PET scan times and PET tracer doses considerably without impacting patients.